Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The role of plasminogen activator inhibitor-1 in gastric mucosal protection.

Kenny S, Steele I, Lyons S, Moore AR, Murugesan SV, Tiszlavicz L, Dimaline R, Pritchard DM, Varro A, Dockray GJ.

Am J Physiol Gastrointest Liver Physiol. 2013 May 1;304(9):G814-22. doi: 10.1152/ajpgi.00017.2013. Epub 2013 Mar 14.

2.

Gastrin stimulates expression of plasminogen activator inhibitor-1 in gastric epithelial cells.

Nørsett KG, Steele I, Duval C, Sammut SJ, Murugesan SV, Kenny S, Rainbow L, Dimaline R, Dockray GJ, Pritchard DM, Varro A.

Am J Physiol Gastrointest Liver Physiol. 2011 Sep;301(3):G446-53. doi: 10.1152/ajpgi.00527.2010. Epub 2010 Dec 30.

3.

Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.

Takeuchi K, Suzuki K, Yamamoto H, Araki H, Mizoguchi H, Ukawa H.

J Physiol Pharmacol. 1998 Dec;49(4):501-13.

PMID:
10069692
4.

Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.

Iwamoto J, Mizokami Y, Takahashi K, Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokobe K, Ito M, Takehara H, Matsuoka T.

Scand J Gastroenterol. 2005 Jul;40(7):783-93.

PMID:
16109653
5.

Gastric expression of plasminogen activator inhibitor (PAI)-1 is associated with hyperphagia and obesity in mice.

Kenny S, Gamble J, Lyons S, Vlatkovic N, Dimaline R, Varro A, Dockray GJ.

Endocrinology. 2013 Feb;154(2):718-26. doi: 10.1210/en.2012-1913. Epub 2012 Dec 18.

6.

Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.

Brzozowski T, Konturek PC, Konturek SJ, Sliwowski Z, Drozdowicz D, Kwiecień S, Pajdo R, Ptak A, Pawlik M, Hahn E.

Dig Liver Dis. 2000 Oct;32(7):583-94.

PMID:
11142556
9.

Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer.

Castelló R, Landete JM, España F, Vázquez C, Fuster C, Almenar SM, Ramón LA, Radtke KP, Estellés A.

Thromb Res. 2007;120(5):753-62. Epub 2007 Jan 29.

PMID:
17258797
10.

Expression of urokinase-type plasminogen activator, its receptor, and its inhibitor in gastric adenocarcinoma tissues.

Hong SI, Park IC, Son YS, Lee SH, Kim BG, Lee JI, Lee TW, Kook YH, Min YI, Hong WS.

J Korean Med Sci. 1996 Feb;11(1):33-7.

11.
12.

Suppression of growth arrest and DNA damage-inducible 45alpha expression confers resistance to sulindac and indomethacin-induced gastric mucosal injury.

Chiou SK, Hodges A, Hoa N.

J Pharmacol Exp Ther. 2010 Sep 1;334(3):693-702. doi: 10.1124/jpet.110.168153. Epub 2010 May 24.

13.

Expression of urokinase-type plasminogen activator and its receptor in gastric fibroblasts and effects of nonsteroidal antiinflammatory drugs and prostaglandin.

Iwamoto J, Takahashi K, Mizokami Y, Otsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokoube K, Matsuoka T.

Dig Dis Sci. 2003 Dec;48(12):2247-56. Erratum in: Dig Dis Sci. 2012 Jan;57(1):262. Iwamoto, Jun-Ichi [corrected to Iwamoto, Junichi]..

PMID:
14714609
15.

Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.

Gutierrez LS, Schulman A, Brito-Robinson T, Noria F, Ploplis VA, Castellino FJ.

Cancer Res. 2000 Oct 15;60(20):5839-47.

16.

Effects of selective cyclooxygenase-2 inhibitor and non-selective NSAIDs on Helicobacter pylori-induced gastritis in Mongolian gerbils.

Bhang CS, Lee HS, Kim SS, Song HJ, Sung YJ, Kim JI, Chung IS, Sun HS, Park DH, Lee YS.

Helicobacter. 2002 Feb;7(1):14-21.

PMID:
11886470
17.

Localization and distribution of tissue type and urokinase type plasminogen activators and their inhibitors Type 1 and 2 in human and rhesus monkey fetal membranes.

Liu YX, Hu ZY, Liu K, Byrne S, Zou RJ, Ny T, d'Lacey C, Ockleford CD.

Placenta. 1998 Mar-Apr;19(2-3):171-80.

PMID:
9548184
18.
19.

The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells.

Iwamoto J, Mizokami Y, Takahashi K, Matsuoka T, Matsuzaki Y.

Helicobacter. 2008 Jun;13(3):174-82. doi: 10.1111/j.1523-5378.2008.00597.x.

PMID:
18466392

Supplemental Content

Support Center